Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke

NCT05585606 is registered in ClinicalTrials.gov with Silver Creek Pharmaceuticals as lead sponsor.

NCT NCT05585606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05585606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
Lead sponsor
Silver Creek Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
October 19, 2022
Completion date
September 15, 2025
Enrollment
120 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke (ais)